While creating capacity for Covid-19 patients was crucial to deal with the initial outbreak, it has slowed down the effective diagnosis and treatment of cancer across the UK. Coping with the pandemic has meant that routine screenings, urgent referrals, and treatments have been delayed or canceled, leading to a huge backlog of patients requiring care. The impact statistics are staggering with urgent cancer referrals down 60%.1 Cancer Research UK states that since lockdown started, around 2 million fewer tests that help diagnose cancer have taken place.
During this whitepaper, Blue Prism outlines how NHS Trusts across the country are capitalising on medical expertise and augmenting it with digital workers to create innovative solutions for better cancer treatment that neither human nor machine could achieve by working independently.
Download now to learn:
Becoming an agile enterprise means operating as a seamless mix of digital workers, human workers, and systems dynamically automating processes everywhere from the back office to the customer experience. You can do this with Blue Prism's intelligent digital workers that are versatile, autonomous, self-organizing, and secure. As a result, you gain better insight and control over the work, create new and transformative ways to operate, and empower people to focus on work that truly matters.
©2021 Blue Prism Limited. “Blue Prism”, the “Blue Prism” logo and Prism device are either trademarks or registered trademarks of Blue Prism Limited and its affiliates. All Rights Reserved.
If your network blocks YouTube, you may not be able to view the video on this page. In this case, please use another device. Pressing play on the video will set third-party YouTube cookies. Please read our Cookies Policy for more information.
Log In
English
